This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (683) Patient-Reported Outcome Measures (PROMs) (372) Quantified Self and Wellness (113) Design and Usability of Medical Devices (141) Assistive Technology for Vision Loss/Impairment (24) Disabilities (157)

Published on in Vol 10, No 1 (2021): January

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/17436, first published .
Effects of the Argus II Retinal Prosthesis System on the Quality of Life of Patients With Ultra-Low Vision Due to Retinitis Pigmentosa: Protocol for a Single-Arm, Mixed Methods Study

Effects of the Argus II Retinal Prosthesis System on the Quality of Life of Patients With Ultra-Low Vision Due to Retinitis Pigmentosa: Protocol for a Single-Arm, Mixed Methods Study

Effects of the Argus II Retinal Prosthesis System on the Quality of Life of Patients With Ultra-Low Vision Due to Retinitis Pigmentosa: Protocol for a Single-Arm, Mixed Methods Study

Authors of this article:

Judith White1 Author Orcid Image ;   Laura Knight1 Author Orcid Image ;   Lyndon da Cruz2 Author Orcid Image ;   Paulo E Stanga3, 4 Author Orcid Image ;   Hannah Patrick5 Author Orcid Image ;   Helen Powell5 Author Orcid Image ;   Lee Berry5 Author Orcid Image ;   Kathleen Withers1 Author Orcid Image ;   Grace Carolan-Rees1 Author Orcid Image ;   Timothy L Jackson6 Author Orcid Image
Article Authors Cited by (5) Tweetations (4) Metrics

Journals

  1. Lindner M, Gilhooley M, Hughes S, Hankins M. Optogenetics for visual restoration: From proof of principle to translational challenges. Progress in Retinal and Eye Research 2022;91:101089 View
  2. Sharif N. Electrical, Electromagnetic, Ultrasound Wave Therapies, and Electronic Implants for Neuronal Rejuvenation, Neuroprotection, Axonal Regeneration, and IOP Reduction. Journal of Ocular Pharmacology and Therapeutics 2023;39(8):477 View
  3. Nguyen X, Moekotte L, Plomp A, Bergen A, van Genderen M, Boon C. Retinitis Pigmentosa: Current Clinical Management and Emerging Therapies. International Journal of Molecular Sciences 2023;24(8):7481 View
  4. Ramirez K, Drew-Bear L, Vega-Garces M, Betancourt-Belandria H, Arevalo J. An update on visual prosthesis. International Journal of Retina and Vitreous 2023;9(1) View
  5. Szabó V, Varsányi B, Barboni M, Takács Á, Knézy K, Molnár M, Nagy Z, György B, Rivolta C. Insights into eye genetics and recent advances in ocular gene therapy. Molecular and Cellular Probes 2025;79:102008 View